SCHEMBL9607734

SCHEMBL9607734

Cc1ccc(-c2nc(C3CCCCC3)nc(Cl)c2OCc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.46
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
ADORA1 P30542 3/20 0.42
PDE10A Q9Y233 1/20 0.41
IGF1R P08069 3/20 0.38
PDE5A O76074 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 2/20 0.36
HTT P42858 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
OPRK1 P41145 1/20 0.36
KMT2A Q03164 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9607731 0.84 PDE5A (0.45) HTR2AHTR2CPDE10AIGF1RPDE5A
SCHEMBL6918472 0.83 HTR2A (0.43) ALOX5HTR2AHTR2CHTR2BADORA1
SCHEMBL9607750 0.78 ALOX5 (0.41) ALOX5HTR2AHTR2CHTR2BADORA1
SCHEMBL9607733 0.75 CNR2 (0.43) L3MBTL1NPC1HTTKDM4EMEN1
SCHEMBL1232782 0.74 HTT (0.42) L3MBTL1NPC1HTTKDM4EMEN1
SCHEMBL9607726 0.73 PDE5A (0.44) HTR2AHTR2CIGF1RPDE5AKDM4E
SCHEMBL18399039 0.71 ALOX5AP (0.41) PDE10AL3MBTL1HTTKDM4EMEN1
SCHEMBL6919137 0.65 PDE10A (0.40) PDE10A
SCHEMBL26136602 0.63 HTR1A (0.47) HTR2CHTR2BIGF1RL3MBTL1ALOX5AP
SCHEMBL21914803 0.63 PRMT5 (0.52) ALOX5IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120136016-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS MERCK SHARP & DOHME LLC 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136016-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS F9, F8, F12 ALOX5 387/4885HTR2A 4274/4885HTR2C 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.